Kinnear Pharmaceuticals Receives Up To $3 Million to Study New Cystic Fibrosis Treatment

The Cystic Fibrosis Foundation has awarded up to $3 million to Kinnear Pharmaceuticals to conduct preclinical testing of a broad-spectrum anti-infective.